PFKFB3 and Sepsis: In this context, the inhibition of PFKFB3 could be therapeutically exploited to dampen the pathogenic activation of glycolysis, and therefore, it is not surprising that such approaches have been shown to alleviate sepsis-related acute lung injury by suppressing inflammatory responses and the apoptosis of alveolar epithelial cells (41).